Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
save search
Sangoma Announces Filing of Form F-3 Resale Registration Statement and Associated Amendment to StarBlue Inc. Purchase Agreement
Published: 2023-03-29 (Crawled : 12:00) - globenewswire.com
SANG | $4.84 2.82% 910
|
Manufacturing
|
| O: 8.08%
H: 0.0%
C: -8.03%
SBNY | News | $3.5 -2.51% 0.0% 250K
|
Finance
|
| O: 0.0%
H: 119.23%
C: 84.62%
agreement
Kona Gold Beverage, Inc’s Ooh La Lemin Lemonades to be Sold in Walmart Stores
Published: 2022-03-07 (Crawled : 14:30) - globenewswire.com
KGKG | $0.0015 -4.35% 15M
|
Manufacturing
|
| O: 12.12%
H: 129.73%
C: 83.78%
store
Lottery.com Secures $50 Million Credit Facility and Successfully Restores Nasdaq Compliance
Published: 2023-08-02 (Crawled : 18:00) - globenewswire.com
LTRY | News | $1.92 2.13% 1.31% 10K
|
|
| O: 5.66%
H: 190.18%
C: 83.04%
nasdaq lottery.com
Baudax Bio Acquires TeraImmune, Inc.
Published: 2023-06-30 (Crawled : 12:00) - globenewswire.com
BXRX | $0.1864 -54.35% 330K
|
Health Technology
|
| O: 23.03%
H: 123.42%
C: 82.81%
Auddia Announces Launch of Its faidr 3.0 Mobile App
Published: 2023-06-12 (Crawled : 12:00) - globenewswire.com
AUUD | $1.85 -4.15% -4.89% 89K
|
Technology Services
|
| O: 54.06%
H: 130.64%
C: 82.72%
mobile
Jasper Therapeutics Announces Positive Clinical Data from a Phase I/II Trial of Briquilimab as a Conditioning Treatment in Sickle Cell Disease and Beta Thalassemia
Published: 2023-01-03 (Crawled : 14:00) - biospace.com/
JSPR | $22.52 4.31% 3.05% 86K
|
|
| O: 210.62%
H: 153.33%
C: 82.67%
treatment disease trial therapeutics positive
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
Published: 2024-02-13 (Crawled : 14:30) - prnewswire.com
FBLG | $10.81 6.5% 5.32% 29K
|
|
| O: 4.05%
H: 100.91%
C: 81.04%
preclinical
Harbor Custom Development, Inc. Announces Buyer Waives All Contingencies on $14,250,000 Sale of Townhomes
Published: 2023-05-10 (Crawled : 13:00) - globenewswire.com
HCDI | $0.199 -24.47% 1.2M
|
Finance
|
| O: -0.84%
H: 233.68%
C: 80.84%
AMTD Digital Inc.: Thank you note to investors and our response to our latest ADS price performance
Published: 2022-08-02 (Crawled : 05:00) - feed.businesswire.com
HKD | $3.08 0.0% 140K
|
|
| O: 25.34%
H: 174.76%
C: 80.54%
response
Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business
Published: 2023-11-17 (Crawled : 14:00) - globenewswire.com
CYTO | $1.4 -0.99% 0.42% 110K
|
Manufacturing
|
| O: 55.66%
H: 207.4%
C: 80.06%
bentrio business therapeutics
Bunker Hill Announces $50 Million Project Finance Package, Mine Purchase, and US EPA Settlement Agreement Amendment
Published: 2021-12-20 (Crawled : 23:00) - globenewswire.com
BHLL | $0.098 -2.0% -12.75% 1.4M
|
Non-Energy Minerals
|
| O: -4.39%
H: 96.57%
C: 79.94%
PepGen Reports Positive Data from Phase 1 Trial of PGN-EDO51 for the Treatment of Duchenne Muscular Dystrophy
Published: 2022-09-28 (Crawled : 11:00) - biospace.com/
PEPG | $11.39 8.12% 6.69% 69K
|
|
| O: 16.92%
H: 111.18%
C: 79.77%
edo51 treatment trial duchenne positive phase 1
Aptevo Therapeutics Reports First Complete Remission, Providing Clinical Update for Its Phase 1b Multi Center, Multi Cohort Expansion Trial in the Treatment of Acute Myeloid Leukemia
Published: 2021-11-23 (Crawled : 13:30) - biospace.com/
APVO | $0.71 -2.39% -3.77% 160K
|
Health Technology
|
| O: 25.38%
H: 132.18%
C: 79.07%
treatment myeloid leukemia phase 1 expansion phase 1b leukemia trial therapeutics apvo436 acute myeloid leukemia phase 2b
Scopus BioPharma Announces FDA Approval of IND Application for Lead Drug Candidate
Published: 2021-05-24 (Crawled : 14:00) - globenewswire.com
SCPS | $0.1682
|
|
| O: -3.69%
H: 247.56%
C: 78.57%
fda biopharma fda approval drug approval application
Friendable Identifies New Opportunity Following TikTok CEO’s Meeting With US Congress March 23, 2023, Allocating Resources to Complete a TikTok Competitive App or White-Label Offering Leveraging Existing and Proprietary Technologies
Published: 2023-03-29 (Crawled : 10:00) - globenewswire.com
FDBL | $0.0001 0.0% 2.8K
|
Information
|
| O: 0.0%
H: 149.09%
C: 78.18%
offering meeting
Senseonics Announces a Positive Coverage Decision for Eversense CGM from EmblemHealth
Published: 2021-01-19 (Crawled : 17:00) - biospace.com/
SENS | $0.3988 -0.1% 0.3% 2.1M
|
Electronic Technology
|
| O: 1.27%
H: 86.25%
C: 78.13%
positive
Mullen Delivers 38 Class 3 Vehicles to Randy Marion Automotive Group
Published: 2023-12-21 (Crawled : 13:00) - globenewswire.com
MULN | News | $2.55 -1.92% -2.56% 1M
|
Information
|
| O: 0.0%
H: 133.75%
C: 78.13%
vehicles group automotive
Asset Entities Announces Stock Repurchase Program
Published: 2023-11-27 (Crawled : 13:00) - globenewswire.com
ASST | $0.4067 1.17% 1.16% 110K
|
|
| O: 12.02%
H: 174.27%
C: 77.76%
repurchase program
Invivyd Announces Positive Initial Results from Ongoing CANOPY Phase 3 Pivotal Clinical Trial Investigating VYD222 for the Prevention of COVID-19
Published: 2023-12-18 (Crawled : 12:00) - globenewswire.com
IVVD | $2.19 -4.78% -4.55% 1.4M
|
Manufacturing
|
| O: 23.93%
H: 133.17%
C: 77.72%
vyd222 covid-19 positive ongoing trial results
BranchOut Food Expands Relationship with Nation’s Largest Retailer, Valued at an estimated $7.6M Annually
Published: 2024-02-12 (Crawled : 13:00) - globenewswire.com
BOF | $1.1 -4.35% -0.88% 8.5K
|
|
| O: 2.37%
H: 155.32%
C: 75.89%
food
Gainers vs Losers
| 73% | 27% |
Top 10 Gainers
MTTR | News M | $4.8 175.86% 63.6% 71M
|
AGBA | $2.5 100.0% 56.6% 200M
|
Finance
MLEC | $2.47 76.43% 42.62% 78M
|
n/a
NUWE | $0.334 29.96% 40.99% 2.5M
|
Manufacturing
EDBL | News | $6.26 66.49% 40.13% 16M
|
ATGL | $2.86 46.25% 32.8% 180K
|
ONFO | $0.6088 38.68% 27.74% 7.3M
|
n/a
VIVK | $1.43 33.65% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.7M
|
SDIG A | $3.64 35.32% 26.0% 990K
|
Your saved searches
Save your searches and get alerts when important news are released.